Branded formulations — specialty and challengers — Business MegaBrands 2026–27
Specialty and challenger branded formulations in India are prescription medicines sold under company brand names, often in chronic therapies such as diabetes, cardiology, dermatology and gynaecology, and promoted to doctors through field teams. These companies widen the choice of therapies available to Indian prescribers. Competition among them also helps keep long-term treatment within reach of more patients.
Slot BMB-168 · Pharmaceuticals · 5 brands in contention · Business MegaBrand: to be announced in 2027
Brands in contention
Listed alphabetically. The order does not reflect evaluation.
| Company | MegaBrands 501 |
|---|---|
| Alembic | |
| Corona Remedies | |
| Eris Lifesciences | |
| FDC | |
| Indoco Remedies |
How this category is evaluated
Every brand in this category is assessed on WCRC's 50-parameter brand evaluation model, across five pillars: Brand Positioning & Recall, Trust & Sentiment, Product, Innovation & Delivery, Sustainability, Governance & ESG, and Digital & Financial Soundness. Scores are compared within the category, and the brand with the strongest result is named the Business MegaBrand. Read the methodology
Frequently asked
Which are the leading specialty pharma companies in India?
In the Business MegaBrands 2026–27 cohort, the brands in contention for specialty and challenger branded formulations are Alembic, Corona Remedies, Eris Lifesciences, FDC and Indoco Remedies. This is a list, not a ranking. WCRC will name one Business MegaBrand after its independent 50-parameter evaluation of every brand in contention.
Other categories in Pharmaceuticals
- Branded formulations — large
- Branded formulations — mid-size
- Export and regulated-market generics — large
- Export generics — mid-size
All of Pharma, Life Sciences & Medtech · The 2026–27 cohort
Cite this page: WCRC, Business MegaBrands 2026–27, Branded formulations — specialty and challengers (Slot BMB-168), https://www.mostvaluablebrands.com/business-megabrands/2026-27/pharma-life-sciences-and-medtech/branded-formulations-specialty-and-challengers/, accessed [date].
WCRC network: WCRC International · WCRC Leaders